Halozyme's attempt to acquire Evotec was a bold move to diversify revenue, but was ultimately unsuccessful, impacting HALO's ...

Current health news highlights the FDA's approval of an injectable Opdivo, Anthem Biosciences' IPO plans, bird flu's ...

FDA approves subcutaneous Opdivo, enhancing cancer treatment with similar efficacy to intravenous form and improved patient ...

This strong market position generates substantial cash flows that support shareholder returns. Turning to the specifics, the ...

2024 saw the establishment of docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil as the preferred regimen for patients ...

UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung ...

Belgium will ban the sale of disposable e-cigarettes starting January 1, 2025. This is a pioneering move in Europe to ...

The Houthis, an Iranian-backed group based in Yemen, have launched repeated attacks despite the Israeli military’s retaliatory airstrikes. By Adam Rasgon Stepped up attacks by Russia are ...

Take a look at this year’s top articles — one showcasing enhanced weight loss through Semaglutide use in post-menopausal ...

It is a fictional representation created for illustrative purposes only. The FDA has sanctioned an injectable form of Bristol ...

NEW YORK – Carsgen Therapeutics on Monday said it plans to seek approval in China for its autologous CAR T-cell therapy satricabtagene autoleucel (satri-cel) in previously treated patients with ...